STOCK TITAN

West Elects New Director to the Board

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management

West Pharmaceutical Services (NYSE: WST) has appointed Janet Haugen to its Board of Directors, expanding the board to 12 members. Haugen, 66, brings extensive financial and technological expertise from her previous role as Chief Financial Officer at Unisys , where she served for over 16 years. During her tenure, she led the company's transformation from a hardware-focused business to an IT services provider. Prior to Unisys, Haugen was a partner at Ernst & Young working with Fortune 500 companies. She currently serves on the boards of Bentley Systems, Juniper Networks, and CentralSquare Technologies. Haugen holds an Economics degree from Rutgers University and is a certified director of the National Association of Corporate Directors.

West Pharmaceutical Services (NYSE: WST) ha nominato Janet Haugen nel suo Consiglio di Amministrazione, aumentando il numero dei membri a 12. Haugen, 66 anni, porta un'ampia esperienza finanziaria e tecnologica dalla sua precedente posizione di Chief Financial Officer presso Unisys, ruolo che ha ricoperto per oltre 16 anni. Durante il suo mandato, ha guidato la trasformazione dell'azienda da un'attività focalizzata sull'hardware a un fornitore di servizi IT. Prima di Unisys, Haugen è stata partner presso Ernst & Young, lavorando con aziende Fortune 500. Attualmente, ricopre incarichi nei consigli di amministrazione di Bentley Systems, Juniper Networks e CentralSquare Technologies. Haugen ha conseguito una laurea in Economia presso la Rutgers University ed è una direttrice certificata della National Association of Corporate Directors.

West Pharmaceutical Services (NYSE: WST) ha nombrado a Janet Haugen en su Junta Directiva, aumentando el número de miembros a 12. Haugen, de 66 años, aporta una amplia experiencia financiera y tecnológica de su anterior puesto como Directora Financiera en Unisys, donde trabajó durante más de 16 años. Durante su gestión, lideró la transformación de la empresa de un negocio centrado en hardware a un proveedor de servicios de TI. Antes de Unisys, Haugen fue socia en Ernst & Young, trabajando con empresas Fortune 500. Actualmente, forma parte de las juntas de Bentley Systems, Juniper Networks y CentralSquare Technologies. Haugen tiene un título en Economía de la Universidad de Rutgers y es directora certificada de la National Association of Corporate Directors.

West Pharmaceutical Services (NYSE: WST)는 Janet Haugen을 이사회에 임명하여 이사회를 12명으로 확장했습니다. 66세의 Haugen은 Unisys에서 CFO로 16년 이상 재직하며 쌓은 폭넓은 금융 및 기술 전문성을 가지고 있습니다. 그동안 그녀는 회사가 하드웨어 중심의 비즈니스에서 IT 서비스 제공자로 변모하는 것을 이끌었습니다. Unisys 이전에는 Fortune 500 기업과 함께 일했던 Ernst & Young의 파트너였습니다. 현재 그녀는 Bentley Systems, Juniper Networks 및 CentralSquare Technologies의 이사회에서 활동하고 있습니다. Haugen은 Rutgers University에서 경제학 학위를 보유하고 있으며, National Association of Corporate Directors의 인증된 이사입니다.

West Pharmaceutical Services (NYSE: WST) a nommé Janet Haugen à son Conseil d'Administration, portant le nombre de membres à 12. Haugen, âgée de 66 ans, apporte une vaste expérience financière et technologique de son précédent rôle de Directrice Financière chez Unisys, où elle a exercé pendant plus de 16 ans. Pendant son mandat, elle a dirigé la transformation de l'entreprise d'une activité axée sur le matériel à un fournisseur de services informatiques. Avant Unisys, Haugen était associée chez Ernst & Young où elle a travaillé avec des sociétés du Fortune 500. Elle siège actuellement aux conseils d'administration de Bentley Systems, Juniper Networks et CentralSquare Technologies. Haugen est diplômée en économie de l'Université de Rutgers et est directrice certifiée de la National Association of Corporate Directors.

West Pharmaceutical Services (NYSE: WST) hat Janet Haugen in seinen Vorstand berufen, womit die Anzahl der Mitglieder auf 12 erhöht wird. Die 66-jährige Haugen bringt umfangreiche Finanz- und Technologiekenntnisse aus ihrer vorherigen Position als Chief Financial Officer bei Unisys mit, wo sie über 16 Jahre tätig war. In ihrer Amtszeit leitete sie die Transformation des Unternehmens von einem hardwareorientierten Geschäft zu einem IT-Dienstleistungsanbieter. Vor Unisys war Haugen Partnerin bei Ernst & Young und arbeitete mit Fortune 500 Unternehmen. Derzeit ist sie in den Vorständen von Bentley Systems, Juniper Networks und CentralSquare Technologies tätig. Haugen hat einen Abschluss in Wirtschaftswissenschaften von der Rutgers University und ist zertifizierte Direktorin der National Association of Corporate Directors.

Positive
  • Addition of director with extensive financial and technology expertise
  • Board member with significant Fortune 500 experience
  • Track record in business transformation and operational oversight
  • Current board experience with multiple technology companies
Negative
  • None.

EXTON, Pa., Dec. 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Janet Haugen as its newest member. With the addition of Ms. Haugen, West's Board has 12 directors.

Ms. Haugen, 66, is the former Chief Financial Officer of Unisys Corporation, a role she served in for more than 16 years. During her 20-year tenure at Unisys, Ms. Haugen oversaw the business transformation from a mainframe hardware, software and maintenance company to an IT services and software provider. In addition to her core finance responsibilities, she had oversight of Unisys' corporate development, IT, procurement, facilities and legal functions.

Prior to joining Unisys, Ms. Haugen was a partner at Ernst & Young working with Fortune 500 companies serving global clients in the technology and manufacturing industries.

Ms. Haugen currently serves on the Board of Directors of Bentley Systems, Juniper Networks and CentralSquare Technologies.

Ms. Haugen earned her degree in Economics from Rutgers University. In addition, she is a certified director of the National Association of Corporate Directors (NACD).

"We are pleased to welcome Janet Haugen to West's Board of Directors," said Paolo Pucci, Lead Independent Director, West. "Janet's unique combination of technology and finance expertise makes her an invaluable addition to our Board of Directors. With her significant board experience and proven operational track record, Janet will help us continue to enhance the impact of West's role to deliver healthcare to millions of patients every day."

About West 
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.    

Headquartered in Exton, Pennsylvania, West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.  

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted. 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/west-elects-new-director-to-the-board-302328461.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

Who is the new board director appointed to West Pharmaceutical Services (WST)?

Janet Haugen, former CFO of Unisys , has been appointed as the newest member of West Pharmaceutical Services' Board of Directors.

What is Janet Haugen's background before joining WST's board?

Haugen served as CFO of Unisys for over 16 years, was a partner at Ernst & Young, and currently serves on the boards of Bentley Systems, Juniper Networks, and CentralSquare Technologies.

How many directors are now on West Pharmaceutical Services' (WST) board?

With Janet Haugen's addition, West Pharmaceutical Services' Board now has 12 directors.

What experience does Janet Haugen bring to WST's board?

Haugen brings expertise in finance and technology, experience in business transformation, and oversight of corporate development, IT, procurement, facilities, and legal functions from her time at Unisys.

West Pharmaceutical Services, Inc.

NYSE:WST

WST Rankings

WST Latest News

WST Stock Data

23.82B
72.00M
0.58%
96.8%
1.79%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
EXTON